The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Anti-vascular endothelial growth factor therapy for ocular neovascular disease
Abstract
PURPOSE OF REVIEW: Recent research has shown that vascular endothelial growth factor (VEGF) is responsible for many ocular pathologies involving neovascularization. Over the past several years several new agents targeting VEGF have become commercially available for intraocular use. These agents have revolutionized the care of neovascular age related macular degeneration and have great potential for other blinding conditions such as diabetic retinopathy, retinopathy of prematurity, and neovascular glaucoma. RECENT FINDINGS: The VEGF Inhibition Study in Ocular Neovascularization (VISION) trial first showed that an anti-VEGF agent (pegaptanib) was able to prevent vision loss in neovascular age related macular degeneration. The Minimally Classic/Occult Trial of Anti-VEGF Antibody Ranibizumab in the Treatment of Neovascular AMD (MARINA) and Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in AMD (ANCHOR) trials showed that ranibizumab prevented moderate vision loss in neovascular age related macular degeneration and for the first time that a substantial proportion of patients regained vision. Smaller case series have shown that bevacizumab can regress retinal, iris and disc neovascularization. Ongoing trials are investigating the utility of anti-VEGF therapy in retinopathy of prematurity, diabetic retinopathy, and neovascular glaucoma. SUMMARY: Newer anti-VEGF therapies have shown unprecedented efficacy in treating age related macular degeneration with many patients experiencing improvement in vision. Ongoing trials will help guide their use in age related macular degeneration and expand their indications to many other blinding diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Oxygen-induced retinopathy in the mouse.
Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D’Amato, R. J., Sullivan, R., & D'Amore, P. A. (1994) · PubMed · Cited by 1,627
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
Adamis, A. P., Miller, J. W., Bernal, M.-T., D'Amico, D. J., Folkman, J., Yeo, T.-K., & Yeo, K.-T. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75794-0 · Cited by 1,296
Self-citationAge-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
Ferris, F. L., Fine, S. L., & Hyman, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040031330019 · Cited by 1,093
Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,027
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Avery, R. L., Pearlman, J., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., Giust, M. J., Wendel, R., & Patel, A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.064 · Cited by 799
Kvanta, A., Algvere, P., Berglin, L., & Seregard, S. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70522-7 · Cited by 620
Drusen and Disciform Macular Detachment and Degeneration
Gass, J. D. M. (1973) · Archives of Ophthalmology · doi:10.1001/archopht.1973.01000050208006 · Cited by 592
Hellstrom, A., Perruzzi, C., Ju, M., Engström, E., Hård, A.-L., Liu, J.-L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Sjödell, L., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101113998 · Cited by 583
Smith, L. E. H., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 556
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin
(2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00544-9 · Cited by 546
Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration
Gaudreault, J., Fei, D., Rusit, J., Suboc, P., & Shiu, V. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0601 · Cited by 501
Argon Laser Photocoagulation for Senile Macular Degeneration: Results of a Randomized Clinical Trial
(1982) · Archives of Ophthalmology · doi:10.1001/archopht.1982.01030030920003 · Cited by 405
Hudson, P. J., & Souriau, C. (2003) · Nature Medicine · doi:10.1038/nm0103-129 · Cited by 398
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Heier, J. S., Antoszyk, A. N., Pavan, P. R., Leff, S. R., Rosenfeld, P. J., Ciulla, T. A., Dreyer, R. F., Gentile, R. C., Sy, J. P., Hantsbarger, G., et al. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.052 · Cited by 360
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes
Tuttle, K. R., Bakris, G. L., Toto, R. D., McGill, J. B., Hu, K., & Anderson, P. W. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2686 · Cited by 300
Tripathi, R. C., Lixa, J., Tripathi, B. J., Chalam, K. V., & Adamis, A. P. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)92782-8 · Cited by 287
Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
(2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.07.032 · Cited by 276
Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration
D’Amico, D. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.027 · Cited by 260
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)
JORGE, R., COSTA, R. A., CALUCCI, D., CINTRA, L. P., & SCOTT, I. U. (2006) · Retina · doi:10.1097/01.iae.0000246884.76018.63 · Cited by 258
The PKC-DRS Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.7.2188 · Cited by 218
RAPID IMPROVEMENT OF RUBEOSIS IRIDIS FROM A SINGLE BEVACIZUMAB (AVASTIN) INJECTION
DAVIDORF, F. H., MOUSER, J. G., & DERICK, R. J. (2006) · Retina · doi:10.1097/00006982-200603000-00017 · Cited by 194
CHEN, E., & PARK, C. H. (2006) · Retina · doi:10.1097/01.iae.0000225351.87205.69 · Cited by 193
Angiogenic Pathways in Diabetic Retinopathy
Aiello, L. P. (2005) · New England Journal of Medicine · doi:10.1056/nejme058142 · Cited by 186
Bressler, N. M. (2001) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · Cited by 170
NGUYEN, Q., SHAH, S., Hafiz, G., Quinlan, E., SUNG, J., CHU, K., Cedarbaum, J. M., & Campochiaro, P. A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.055 · Cited by 157
Mason, J. O., Nixon, P. A., & WHITE, M. F. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.04.058 · Cited by 154
Intravitreal Bevacizumab in a Patient With Neovascular Glaucoma
Kahook, M. Y., Schuman, J. S., & Noecker, R. J. (2006) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/1542-8877-20060301-11 · Cited by 137
Young, T. L., Anthony, D. C., Pierce, E. A., Foley, E., & Smith, L. E. H. (1997) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1016/s1091-8531(97)90008-2 · Cited by 116
Konner, J. A., & Dupont, J. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.s.013 · Cited by 90
Strøm, C., Sander, B., Klemp, K., Aiello, L. P., Lund‐Andersen, H., & Larsen, M. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0096 · Cited by 59
Takahashi, H., Obata, R., & Tamaki, Y. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.213 · Cited by 45
Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
Kinose, F., Roscilli, G., Lamartina, S., Anderson, K. D., Bonelli, F., Spence, S., Ciliberto, G., Vogt, T., Holder, D., Toniatti, C., et al. (2005) · PubMed · Cited by 42
一史美, 吉., Shi, G., Niesman, M. R., Rewolinski, D. A., & Miller, S. S. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.01.022 · Cited by 10
Cited by
Consequences of oxidative stress in age-related macular degeneration
Jarrett, S. G., & Boulton, M. E. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.009 · Cited by 538
Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
Ramakrishnan, S., Anand, V., & Roy, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9531-7 · Cited by 442
Bazan, N. G., Molina, M. F., & Gordon, W. C. (2011) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104635 · Cited by 441
Transcriptional Control of Endothelial Cell Development
De Val, S., & Black, B. L. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.014 · Cited by 346
“Finally, aberrant blood vessel growth is a significant cause of age-related macular degeneration, and excessive blood vessel growth underlies proliferative diabetic retinopathy (Andreoli and Miller, 2007; Simo et al., 2006).”
BackgroundCombinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription Factors
De Val, S., Chi, N. C., Meadows, S. M., Minovitsky, S., Anderson, J. P., Harris, I. S., Ehlers, M. L., Agarwal, P., Visel, A., Xu, S.-M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.049 · Cited by 343
Metadata
- Authors
- Andreoli, C. M., & Miller, J. W.
- Venue
- Current Opinion in Ophthalmology
- Published
- 2007-11
- Volume
- 18
- Issue
- 6
- Pages
- 502-508
- ISSN
- 1040-8738 (ISSN-L)
- OpenAlex
- W2047301512
- Cited by
- 274
- References
- 40
- FWCI
- 27.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.